FACULTY PRESENTERS
Martin H. Steinberg, MD
Professor of Medicine, Pediatrics, Pathology and Laboratory Medicine
Division of Hematology/Oncology
Boston University School of Medicine
Boston, MA
Michael White, MD, MSC
Pediatric Hematology/Oncology,
Aflac Cancer & Blood Disorders Center
Children’s Healthcare of Atlanta
Assistant Professor of Pediatrics,
Emory University School of Medicine
Atlanta, GA
PROGRAM OVERVIEW
Recent advances in treatment strategies promise to improve the lives of patients with sickle cell disease or hemophilia. In this program, experts in both fields will assist clinicians in developing individualized management plans using state-of-the-art and emerging therapies, and highlight opportunities to implement multidisciplinary, patient-centered approaches to care. Case studies and interactive question and answers will provide learners practice in applying patient-specific factors to treatment decisions. This activity will feature whiteboard animations that will reinforce learning and help participants gain a higher level of understanding.
TARGET AUDIENCE
This activity is designed to meet the educational needs of hematologists, emergency medicine physicians and other healthcare practitioners who treat patients with hemophilia A or B and SCD.
LEARNING OBJECTIVES
Upon the completion of this program, attendees should be able to:
- Evaluate evidence from clinical trials assessing available and emerging therapies for the treatment of patients with chronic hematologic conditions including hemophilia and SCD
- Evaluate patient-specific characteristics when developing individualized management plans for those with chronic hematologic conditions including hemophilia and SCD
- Facilitate a multidisciplinary patient-centered SDM approach to the management of those with chronic hematologic conditions including hemophilia and SCD
ACCREDITATION STATEMENT
Med Learning Group is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. This CME activity was planned and produced in accordance with the ACCME Essentials.
CREDIT DESIGNATION STATEMENT
Med Learning Group designates this online activity for a maximum of 1.5 AMA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the online activity.
NURSING CREDIT INFORMATION
Purpose: This program would be beneficial for nurses involved in the care of patients with chronic hematologic conditions including hemophilia and SCD.
CNE Credits: 1.5 ANCC Contact Hour.
CNE ACCREDITATION STATEMENT
Ultimate Medical Academy/CCM is accredited as a provider of nursing continuing professional education development by the American Nurses Credentialing Center’s Commission on Accreditation.
Awarded 1.5 contact hour of continuing nursing education of RNs and APNs.
DISCLOSURE POLICY STATEMENT
In accordance with the Accreditation Council for Continuing Medical Education (ACCME) Standards for Commercial Support, educational programs sponsored by Med Learning Group must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff, and planning committee members participating in an MLG-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.
DISCLOSURE OF CONFLICTS OF INTEREST
| Faculty Member | Disclosures |
| Martin H. Steinberg, MD | Dr. Steinberg is a consultant for Vertex Pharmaceuticals, Alexion, Astellas/Mitobridge, and Fulcrum Therapeutics. He is also a member of the Data Monitoring Committee for Imara. |
| Michael White, MD, MSC | Dr. White has received a research fellowship award from the National Hemophilia Foundation – Takeda. |
CME Content Review
The content of this activity was independently peer reviewed.
The reviewer of this activity has nothing to disclose.
CNE Content Review
The content of this activity was peer reviewed by a nurse reviewer.
Douglas Cox, MSN, MHA, RN
Ultimate Medical Academy/CCM – Lead Nurse Planner
The reviewer of this activity has nothing to disclose
Staff Planners and Managers
The staff, planners, and managers reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME/CE activity:
Matthew Frese, MBA, General Manager of Med Learning Group, has nothing to disclose.
Christina Gallo, SVP, Educational Development for Med Learning Group, has nothing to disclose.
Douglas Cox, MSN, MHA, RN, has nothing to disclose.
Cindy Lampner, MSLIS, Medical Director for Med Learning Group, has nothing to disclose.
Lauren Welch, MA, VP, Accreditation and Outcomes for Med Learning Group, has nothing to disclose.
Lisa Crenshaw, Senior Program Manager for Med Learning Group, has nothing to disclose.
Russie Allen, Accreditation and Outcomes Coordinator of Med Learning Group, has nothing to disclose.
DISCLOSURE OF UNLABELED USE
Med Learning Group requires that faculty participating in any CME activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States.
During this lecture, the faculty may mention the use of medications for both FDA-approved and non-approved indications.
METHOD OF PARTICIPATION
There are no fees for participating and receiving CME credit for this online activity. To receive CME/CNE credit participants must:
- Read the CME/CNE information and faculty disclosures.
- Participate in the online activity.
- Submit the evaluation form to Med Learning Group.
DISCLAIMER
Med Learning Group makes every effort to develop CME activities that are science based. This activity is designed for educational purposes. Participants have a responsibility to use this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision making before applying any information, whether provided here or by others, for any professional use.
For CME questions, please contact Med Learning Group at [email protected].
Contact this CME provider at Med Learning Group for privacy and confidentiality policy statement information at https://medlearninggroup.com/privacy-policy/
AMERICANS WITH DISABILITIES ACT
Staff will be glad to assist you with any special needs. Please contact Med Learning Group prior to participating at [email protected]
Copyright © 2021 Med Learning Group. All rights reserved. These materials may be used for personal use only. Any rebroadcast, distribution, or reuse of this presentation or any part of it in any form for other than personal use without the express written permission of Med Learning Group is prohibited.
